Growth Equity Opportunities V LLC 13D and 13G filings for Regulus Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-03-18 9:13 pm Purchase | 2024-03-14 | 13D | Regulus Therapeutics Inc. RGLS | Growth Equity Opportunities V LLC | 6,533,102 9.990% | 4,587,523 (+235.79%) | Filing |
| 2023-05-12 1:57 pm Purchase | 2023-04-13 | 13D | Regulus Therapeutics Inc. RGLS | Growth Equity Opportunities V LLC | 1,945,579 9.990% | 487,327 (+33.42%) | Filing |
| 2021-12-09 2:58 pm Purchase | 2021-11-30 | 13D | Regulus Therapeutics Inc. RGLS | Growth Equity Opportunities V LLC | 1,458,252 9.990% | 1,253,007 (+610.49%) | Filing |